Загрузка...

Major histocompatibility complex class II molecule in non-small cell lung cancer diagnosis, prognosis and treatment

Lung cancer is one of the commonest cancers in the world. More than 70% of lung cancer patients are diagnosed with non-small cell lung cancer (NSCLC). Major histocompatibility complex class II (MHC class II), an important component in antigen presenting process, usually expresses on professional ant...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Onco Targets Ther
Главные авторы: Wang, Hao, Zhao, Sha, Zhang, Xiaoshen, Jia, Keyi, Deng, Juan, Zhou, Caicun, He, Yayi
Формат: Artigo
Язык:Inglês
Опубликовано: Dove 2019
Предметы:
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6733341/
https://ncbi.nlm.nih.gov/pubmed/31564911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S214231
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!